# A Study of TAK-102 in Adult With Previously-Treated Solid Tumors

> **NCT04405778** · PHASE1 · TERMINATED · sponsor: **Takeda** · enrollment: 12 (actual)

## Conditions studied

- Solid Tumors

## Interventions

- **BIOLOGICAL:** TAK-102

## Key facts

- **NCT ID:** NCT04405778
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-10
- **Primary completion:** 2025-05-09
- **Final completion:** 2025-05-09
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Business decision unrelated to patient safety
- **Last updated:** 2025-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04405778

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04405778, "A Study of TAK-102 in Adult With Previously-Treated Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04405778. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*